Wednesday, Sep 4, 2002

Genentech Names Stephen G. Juelsgaard Executive Vice President

South San Francisco, Calif. -- September 4, 2002 --

Genentech, Inc. (NYSE: DNA) announced today the promotion of Stephen G. Juelsgaard, D.V.M., J.D. to executive vice president, general counsel and secretary. 

In his position, Juelsgaard, 53, is responsible for managing Genentech’s Legal department, which handles the company’s corporate and patent law matters. He also oversees the company’s Human Resources department.

“This promotion is a reflection of Steve’s many significant contributions to Genentech as well as his strong leadership abilities and high level of expertise and experience,” said Arthur D. Levinson, Ph.D., Genentech's chairman and chief executive officer.

Juelsgaard joined Genentech in 1985 as corporate counsel.  In 1992 he became vice president, Corporate Law, and in 1994 he was named vice president and general counsel.  He was named secretary in 1997 and senior vice president in 1998.  In 2001, Juelsgaard assumed additional responsibility for the company’s Human Resources department.

Prior to his employment with Genentech, Juelsgaard was an associate with the law firm of Wilson Sonsini Goodrich & Rosati. He holds a doctorate of veterinary medicine and a Master of Science degree from Iowa State University and a law degree from Stanford Law School.

Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs.  Fifteen of the currently approved biotechnology products originated from or are based on Genentech science. Genentech manufactures and commercializes ten biotechnology products directly in the United States.  The company has headquarters in South San Francisco, California, and is traded on the New York Stock Exchange under the symbol DNA.